PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $66,000 | -77.6% | 21,600 | -72.3% | 0.01% | -81.4% |
| Q4 2021 | $295,000 | +619.5% | 77,985 | +622.1% | 0.04% | +616.7% |
| Q2 2021 | $41,000 | -43.1% | 10,800 | -46.0% | 0.01% | -60.0% |
| Q4 2019 | $72,000 | -51.0% | 20,000 | -53.7% | 0.02% | -60.5% |
| Q3 2019 | $147,000 | -30.7% | 43,231 | -3.9% | 0.04% | -38.7% |
| Q2 2019 | $212,000 | +40.4% | 45,000 | 0.0% | 0.06% | +40.9% |
| Q1 2019 | $151,000 | +7.1% | 45,000 | -15.3% | 0.04% | +22.2% |
| Q4 2018 | $141,000 | -44.0% | 53,159 | +18.1% | 0.04% | -25.0% |
| Q3 2018 | $252,000 | +10.5% | 45,000 | 0.0% | 0.05% | -56.8% |
| Q2 2018 | $228,000 | +67.6% | 45,000 | +125.0% | 0.11% | +246.9% |
| Q1 2018 | $136,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |